<!DOCTYPE html>
<html lang="ko">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Success Stories</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 100vh;
        }
        
        .container {
            width: 960px;
            height: 540px;
            padding: 40px;
            background: white;
        }
        
        .title {
            font-size: 32px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .success-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 20px;
        }
        
        .success-card {
            background: linear-gradient(135deg, #f8f9fb 0%, #e8f2ff 100%);
            border: 3px solid #1E64C8;
            border-radius: 12px;
            padding: 22px;
            transition: all 0.3s;
        }
        
        .success-card:hover {
            transform: translateY(-8px);
            box-shadow: 0 12px 30px rgba(30, 100, 200, 0.25);
        }
        
        .success-title {
            font-size: 20px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 10px;
        }
        
        .success-drug {
            font-size: 16px;
            font-weight: 600;
            color: #333;
            margin-bottom: 8px;
        }
        
        .success-description {
            font-size: 15px;
            color: #555;
            line-height: 1.5;
        }
        
        .highlight {
            color: #1E64C8;
            font-weight: 600;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">ðŸŽ¯ Precision Medicine Success Stories</div>
        
        <div class="success-grid">
            <div class="success-card">
                <div class="success-title">HER2+ Breast Cancer</div>
                <div class="success-drug">Trastuzumab (Herceptin)</div>
                <div class="success-description">
                    First companion diagnostic: <span class="highlight">HER2 testing</span> identifies patients who benefit from targeted therapy. Dramatically improved survival in HER2+ patients.
                </div>
            </div>
            
            <div class="success-card">
                <div class="success-title">CML Treatment Revolution</div>
                <div class="success-drug">Imatinib (Gleevec)</div>
                <div class="success-description">
                    Targeting <span class="highlight">BCR-ABL fusion</span> transformed CML from fatal to manageable chronic disease. 5-year survival >90%.
                </div>
            </div>
            
            <div class="success-card">
                <div class="success-title">MSI-High Cancers</div>
                <div class="success-drug">Pembrolizumab (Keytruda)</div>
                <div class="success-description">
                    First tissue-agnostic approval based on <span class="highlight">MSI biomarker</span>. Immunotherapy success across multiple cancer types.
                </div>
            </div>
            
            <div class="success-card">
                <div class="success-title">Melanoma Breakthrough</div>
                <div class="success-drug">BRAF Inhibitors</div>
                <div class="success-description">
                    <span class="highlight">BRAF V600E mutation</span> testing enables combination therapy. Median survival improved from 9 to 25+ months.
                </div>
            </div>
            
            <div class="success-card">
                <div class="success-title">CAR-T Cell Therapy</div>
                <div class="success-drug">Tisagenlecleucel (Kymriah)</div>
                <div class="success-description">
                    <span class="highlight">CD19+ B-cell</span> targeting in leukemia/lymphoma. Complete remission in 80%+ of refractory patients.
                </div>
            </div>
            
            <div class="success-card">
                <div class="success-title">ðŸ’¡ Key Lessons</div>
                <div class="success-description" style="margin-top: 10px;">
                    â€¢ Strong biomarker-target link<br>
                    â€¢ Rigorous validation studies<br>
                    â€¢ Drug-diagnostic co-development
                </div>
            </div>
        </div>
    </div>
</body>
</html>